Effect of fluoridation of hydroxyapatite in hydroxyapatite-polycaprolactone composites on osteoblast activity
- 1 July 2005
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 26 (21), 4395-4404
- https://doi.org/10.1016/j.biomaterials.2004.11.008
Abstract
Fluorine was administered to a system of hydroxyapatite (HA)/polycaprolactone (PCL) ceramic-polymer bioactive composites for applications as hard tissue regeneratives. The HA was fluoridated at different levels (5%, 25%, 50% and 75%) in order to produce the fluor-hydroxyapatite (FHA)/PCL composites. The osteoblastic cellular responses to the composites were examined in terms of the cell attachment, proliferation and differentiation as well as the expression of bone-associated genes. The amount of fluorine released from the composites was controlled by changing the degree of fluoridation, and the cellular responses were strongly influenced by the level of fluoridation. The MG63 cells on the FHA-PCL attached and proliferated at a similar level to those on HA-PCL. However, the fluoridation of HA increased significantly the alkaline phosphatase (ALP) activity and osteocalcin (OC) production by the cells on the composites, which was measured by an enzymatic assay. Moreover, the gene expression level of ALP and OC in the cells was up regulated on the FHA-PCL, which was confirmed semi-quantitatively by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. These findings on the fluorine-administered biological composites (FHA-PCL) suggested that fluorine plays a significant role in stimulating the bone derived cellular activity, and the FHA-PCL composites have high potential for use as hard tissue regeneratives.Keywords
This publication has 28 references indexed in Scilit:
- Sintered hydroxyfluorapatites—IV: the effect of fluoride substitutions upon colonisation of hydroxyapatites by mouse embryonic stem cellsBiomaterials, 2004
- Hydroxyapatite and fluor‐hydroxyapatite layered film on titanium processed by a sol–gel route for hard‐tissue implantsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2004
- Development of guided bone regeneration membrane composed of β-tricalcium phosphate and poly (l-lactide-co-glycolide-co-ε-caprolactone) compositesBiomaterials, 2004
- Controlled degradation and macrophage responses of a fluoride‐treated polycaprolactoneJournal of Biomedical Materials Research Part A, 2004
- Pressureless Sintering and Mechanical and Biological Properties of Fluor‐hydroxyapatite Composites with ZirconiaJournal of the American Ceramic Society, 2003
- Development of a porous poly(L‐lactic acid)/hydroxyapatite/collagen scaffold as a BMP delivery system and its use in healing canine segmental bone defectJournal of Biomedical Materials Research Part A, 2003
- Long‐term study of high‐strength hydroxyapatite/poly(L‐lactide) composite rods for the internal fixation of bone fractures: A 2–4‐year follow‐up study in rabbitsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2003
- 1,25-dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cellsJournal of Bone and Mineral Research, 1993
- Composites for bone replacementJournal of Biomedical Engineering, 1988
- SODIUM FLUORIDE STIMULATES OSTEOCALCIN IN NORMAL SUBJECTSClinical Endocrinology, 1988